On March 4, AbbVie Inc (NYSE:ABBV) and Pharmacyclics (NASDAQ: PCYC) announced a definitive agreement under which AbbVie will acquire Pharmacyclics, and its flagship asset Imbruvica® (ibrutinib), a highly effective treatment for hematologic malignancies. On Wednesday shares of AbbVie Inc. (NYSE:ABBV) closed at $56.62. Company’s sales growth for last 5 years was 7.00% and EPS growth for next 5 years is recorded as 15.40%.
Oncothyreon Inc (NASDAQ:ONTY) reported Q4 EPS of ($0.30), $0.21 worse than the analyst estimate of ($0.09). Oncothyreon Inc (NASDAQ:ONTY) in last trading activity moved up 6.33% to close at $1.68. Company weekly performance is 3.07% while its quarterly performance stands at 0.60%. Oncothyreon Inc (NASDAQ:ONTY) is -58.82% away from its 52 week high.
Equities research analysts at JPMorgan Chase & Co. raised their target price on shares of BP plc (LON:BP)from GBX 400 ($6.03) to GBX 410 ($6.18) in a research note issued to investors on Thursday. The firm currently has an “underweight” rating on the stock. JPMorgan Chase & Co.’s price objective indicates a potential downside of 3.56% from the company’s current price. On Wednesday shares of BP p.l.c. (NYSE:BP) closed at $38.23. Company’s sales growth for last 5 years was 8.10% and EPS growth for next 5 years is recorded as 8.30%.
Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) said Tuesday that in the wake of the reduced number of working days in February, its sales fell 28.1 percent from January. The decline had been widely anticipated by the market due to slow-season effects in the first quarter for the global semiconductor industry. Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) in last trading activity increased 1.91% to close at $23.49. Company weekly performance is -3.45% while its quarterly performance stands at 4.40%. Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) is -7.23% away from its 52 week high.
On March 7, it was reported that, Bank of Montreal (NYSE:BMO) awarded Chief Executive Officer William Downe C$9.96 million ($7.89 million) in compensation for 2014, a 4.9 percent increase from a year earlier. Downe, 62, received about C$1.59 million in salary, C$8.35 million in shares, stock options and incentives, plus C$14,218 in other compensation for the fiscal year ended Oct. 31, the Toronto-based lender said in a filing to Canadian regulators. He received C$9.49 million for 2013. The totals exclude pension costs. On last trading day Bank of Montreal (NYSE:BMO) moved up 0.14% to close at $59.25. Its volatility for the week is 1.57% while volatility for the month is 1.62%. BMO’s sales growth for past 5 years was 4.30% and its EPS growth for past 5 years was 14.30%. Bank of Montreal (NYSE:BMO) monthly performance is -5.25%.